600420 On Other Exchanges
Symbol
Exchange
600420 is not on other exchanges.

shanghai shyndec pharmaceu-a (600420) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SHANGHAI SHYNDEC PHARMACEU-A (600420)

Related News

No related news articles were found.

shanghai shyndec pharmaceu-a (600420) Related Businessweek News

No Related Businessweek News Found

shanghai shyndec pharmaceu-a (600420) Details

Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, such as product formulations. The company’s products include offers macrolides, antineoplastics, hormones, antibiotics, dermatology drugs, sedative-hypnotics, and external and gynecological suppositories; cardiovascular, anti-virus, and weight loss products; and various drugs for prostate disorders and diabetes medication. Its products also comprise azithromycin and nifedipine controlled-release tablets; cefalexin and cefaclor sustained-release capsules; enalapril maleate tablets; and sustained-release suspension of dextromethorphan and azithromycin, zidovudine, drospirenone, lipoic acid, and other raw materials and products. The company markets its products under the Shenkar, Shen Luo, Xiaomei, PU Yue Qi, Pu Rainbow, pleased, PU Hui-Zhi, excellent Xin Zhi, supporting sling, Pu Xiu, and other brands. Shanghai Shyndec Pharmaceutical Co., Ltd. is based in Shanghai, China.

14,711 Employees
Last Reported Date: 03/22/17

shanghai shyndec pharmaceu-a (600420) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanghai shyndec pharmaceu-a
Shanghai Shyndec Pharmaceutical Co., Ltd. Announces Cash Dividend Payable on May 25, 2017

Shanghai Shyndec Pharmaceutical Co., Ltd. announced a cash dividend of RMB 0.26 (taxes included) per A share, payable on May 25, 2017. Record date is May 24, 2017 and ex-dividend date is May 25, 2017.

Shanghai Shyndec Pharmaceutical Co., Ltd. Announces Profit Distribution Plan for 2016

Shanghai Shyndec Pharmaceutical Co., Ltd. announced profit distribution plan for 2016. The company plans to pay a tax included cash dividend of CNY 2.6 per ten shares for 2016.

Shanghai Shyndec Pharmaceutical Co., Ltd., Board Meeting, Apr 20, 2017

Shanghai Shyndec Pharmaceutical Co., Ltd., Board Meeting, Apr 20, 2017. Agenda: To discuss and approve issues including the proposal of first quarter report of 2017; to consider the proposal of financial budget report in 2017; and to consider the proposal of appointing general manager.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

600420 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600420.
View Industry Companies
 

Industry Analysis

600420

Industry Average

Valuation 600420 Industry Range
Price/Earnings 29.8x
Price/Sales 1.9x
Price/Book 3.0x
Price/Cash Flow 32.6x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHANGHAI SHYNDEC PHARMACEU-A, please visit www.shyndec.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.